CD8A and colorectal cancer: In colorectal cancer models, it increases CD8+ T cell infiltration and cytotoxicity while reducing the abundance of regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs), thus reversing immunosuppressive conditions (47).